Obesity, lymphadenectomy and survival outcomes in intermediate to high-risk, early-stage endometrial cancer patients.

AIM Lymphadenectomy or lymph node dissection is a topic of controversy in endometrial cancer (EC) treatment. MATERIALS & METHODS Associations between lymph node dissections and clinical factors were retrospectively examined in obese, endometrioid endometrial cancer patients with early-stage disease between 1995 and 2005. Overall, EC-specific and recurrence-free survival were also evaluated. RESULTS Out of 192 patients, 61 (32%) did not have a lymph node examination, 55 (29%) had less than ten lymph nodes removed and 76 (39%) had ≥10 removed. Lymph node dissection count was not significantly associated with overall, EC-specific or recurrence-free survival. CONCLUSION Analysis revealed no significant associations between ≥10 dissected lymph nodes and survival outcomes among obese, EC patients, which supports the need for additional investigation of the merit of lymphadenectomy among these patients.

[1]  J. Vidart,et al.  Impact of the Lymphadenectomy in High-Risk Histologic Types of Endometrial Cancer: A Matched-Pair Study , 2014, International Journal of Gynecologic Cancer.

[2]  E. Darai,et al.  Survival Impact of Lymphadenectomy Stratified by Nodal Metastatic Probability in Endometrial Cancer , 2014, Annals of Surgical Oncology.

[3]  H. Watari,et al.  Tailoring lymphadenectomy according to the risk of lymph node metastasis in endometrial cancer , 2014, The journal of obstetrics and gynaecology research.

[4]  H. Watari,et al.  Proposal of a concept and design of a randomized phase III trial investigating the survival effect of para‐aortic lymphadenectomy in endometrial cancer , 2014, The journal of obstetrics and gynaecology research.

[5]  F. Ghezzi,et al.  Role of pelvic and para‐aortic lymphadenectomy in endometrial cancer: Current evidence , 2014, The journal of obstetrics and gynaecology research.

[6]  M. Muto,et al.  The Role of Para-Aortic Lymphadenectomy in the Surgical Staging of Women with Intermediate and High-Risk Endometrial Adenocarcinomas , 2013, International journal of surgical oncology.

[7]  Haiyan Zhang,et al.  A cohort study evaluating paraaortic lymphadenectomy in endometrial cancer. , 2012, Oncology letters.

[8]  L. Havrilesky,et al.  Beyond mere obesity: effect of increasing obesity classifications on hysterectomy outcomes for uterine cancer/hyperplasia. , 2012, Gynecologic oncology.

[9]  D. Mcmeekin.  Designing the next lymphadenectomy trial: what should we learn for our prior experiences. , 2012, Gynecologic oncology.

[10]  H. Chung,et al.  Systematic lymphadenectomy for survival in patients with endometrial cancer: a meta-analysis. , 2012, Japanese journal of clinical oncology.

[11]  W. Gotlieb,et al.  Controversies in the Treatment of Early Stage Endometrial Carcinoma , 2012, Obstetrics and gynecology international.

[12]  B. Kong,et al.  Therapeutic role of systematic retroperitoneal lymphadenectomy in endometrial cancer. , 2012, Bulletin du cancer.

[13]  N. Berger,et al.  Quality of Life in Endometrial Cancer Survivors: What Does Obesity Have to Do with It? , 2011, Obstetrics and gynecology international.

[14]  R. Stone,et al.  Factors associated with Type I and Type II endometrial cancer , 2010, Cancer Causes and Control.

[15]  D. Cohn,et al.  Lymphadenectomy for endometrial cancer: the controversy. , 2010, Gynecologic oncology.

[16]  T. Herzog,et al.  ASTEC lymphadenectomy and radiation therapy studies: are conclusions valid? , 2010, Gynecologic oncology.

[17]  J. W. Kim,et al.  Benefit of Lymphadenectomy in Endometrial Cancer: Can the Truth Be Obtained by Randomized Controlled Trial After ASTEC? , 2009, International Journal of Gynecologic Cancer.

[18]  A. Fader,et al.  Endometrial cancer and obesity: epidemiology, biomarkers, prevention and survivorship. , 2009, Gynecologic oncology.

[19]  V. Torri,et al.  Systematic pelvic lymphadenectomy vs. no lymphadenectomy in early-stage endometrial carcinoma: randomized clinical trial. , 2009, Journal of the National Cancer Institute.

[20]  M. Parmar,et al.  Efficacy of systematic pelvic lymphadenectomy in endometrial cancer (MRC ASTEC trial): a randomised study , 2009, The Lancet.

[21]  E. Taioli,et al.  Factors influencing endometrial cancer mortality: the Western Pennsylvania Registry. , 2008, Future oncology.

[22]  K. Münstedt,et al.  Influence of body mass index on prognosis in gynecological malignancies , 2008, Cancer Causes & Control.

[23]  R. Barakat,et al.  Is there a therapeutic impact to regional lymphadenectomy in the surgical treatment of endometrial carcinoma? , 2008, American journal of obstetrics and gynecology.

[24]  J. Pezzullo,et al.  Is Body Mass Index an Independent Risk Factor of Survival Among Patients With Endometrial Cancer? , 2007, American journal of clinical oncology.

[25]  R. Barakat,et al.  Treatment effects, disease recurrence, and survival in obese women with early endometrial carcinoma , 2006, Cancer.

[26]  J. Chan,et al.  Therapeutic role of lymph node resection in endometrioid corpus cancer , 2006, Cancer.

[27]  A. Trentham-Dietz,et al.  Obesity, diabetes, and other factors in relation to survival after endometrial cancer diagnosis , 2006, International Journal of Gynecologic Cancer.

[28]  A. Berchuck,et al.  Pelvic lymph node count is an important prognostic variable for FIGO stage I and II endometrial carcinoma with high-risk histology , 2006 .

[29]  A. Berchuck,et al.  Retrospective analysis of selective lymphadenectomy in apparent early-stage endometrial cancer. , 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[30]  K. Courneya,et al.  Associations among exercise, body weight, and quality of life in a population-based sample of endometrial cancer survivors. , 2005, Gynecologic oncology.

[31]  E. Swisher,et al.  The effect of body mass index on clinical/pathologic features, surgical morbidity, and outcome in patients with endometrial cancer. , 2003, Gynecologic oncology.

[32]  R. Buller,et al.  Obesity and prognosis in endometrial cancer. , 1996, American journal of obstetrics and gynecology.

[33]  R. Kurman,et al.  Relationship between surgical-pathological risk factors and outcome in clinical stage I and II carcinoma of the endometrium: A gynecologic oncology group study , 1991 .